Suppr超能文献

使用高选择性β受体拮抗剂测定大鼠离体心室肌细胞上的β肾上腺素能受体亚型

Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.

作者信息

Kitagawa Y, Adachi-Akahane S, Nagao T

机构信息

Department of Toxicology and Pharmacology, Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.

出版信息

Br J Pharmacol. 1995 Sep;116(1):1635-43. doi: 10.1111/j.1476-5381.1995.tb16384.x.

Abstract
  1. The relative proportions of beta 1- and beta 2-adrenoceptors were determined by radioligand binding studies in three different rat myocardial preparations: membranes prepared from rat ventricle (ventricular membranes), membranes prepared from rat isolated ventricular myocytes (myocyte membranes), and myocytes isolated from rat ventricle (myocytes). 2. Competition experiments using CGP 20712A or ICI 118,551 with [125I]-iodocyanopindolol ([125I]-ICYP) revealed high- and low-affinity binding sites in ventricular membranes. The concentration at which each beta-antagonist occupied 100% of its high-affinity binding sites was 300 nM for CGP 20712A (beta 1-adrenoceptor) and 50 nM for ICI 118,551 (beta 2-adrenoceptor). 3. The density of high-affinity (beta 1-adrenoceptor) and low-affinity (beta 2-adrenoceptor) binding sites for CGP 20712A was measured by a saturation experiment using [125I]-ICYP in the presence and absence of 300 nM CGP 20712A. In ventricular membranes, the proportions of high-affinity and low-affinity binding sites for CGP 20712A were 73% and 27%, respectively, whereas in myocyte membranes, the corresponding figures were 90% and 10%, respectively. The density of low-affinity binding sites for CGP 20712A in ventricular membranes, defined as [125I]-ICYP-specific binding in the presence of 300 nM CGP 20712A, was decreased by addition of 50 nM ICI 118,551, whereas that in myocyte membranes was not affected. 4. In myocytes, specific binding of [125I]-ICYP and [3H]-CGP 12177 was not detected by saturation experiments performed in the presence of 300 nM CGP 20712A. 5 In myocytes, the activation of adenylate cyclase caused by beta2-adrenoceptors was not detected in the presence of 10 nM, 100 nM or 1000 nM CGP 20712A, which selectively antagonized beta1-adrenoceptors.Furthermore, the concentration-response curve for isoprenaline-stimulated cyclic AMP accumulation was not shifted by 10 nm or 100 nM ICI 118,551, which selectively antagonized beta2-adrenoceptors, but was shifted to the right by 1000 nM ICI 118,551.6 These results indicate that beta2-adrenoceptors are not present on rat ventricular myocytes and that beta2-adrenoceptor stimulation does not cause any detectable production of cyclic AMP. We conclude that only beta1-adrenoceptors exist on rat ventricular myocytes.
摘要
  1. 通过放射性配体结合研究,在三种不同的大鼠心肌制剂中测定了β1和β2肾上腺素能受体的相对比例:从大鼠心室制备的膜(心室膜)、从大鼠分离的心室肌细胞制备的膜(肌细胞膜)以及从大鼠心室分离的肌细胞(肌细胞)。2. 使用CGP 20712A或ICI 118,551与[125I] - 碘氰吲哚洛尔([125I] - ICYP)进行的竞争实验揭示了心室膜中的高亲和力和低亲和力结合位点。每种β拮抗剂占据其高亲和力结合位点100%时的浓度,对于CGP 20712A(β1肾上腺素能受体)为300 nM,对于ICI 118,551(β2肾上腺素能受体)为50 nM。3. 通过在存在和不存在300 nM CGP 20712A的情况下使用[125I] - ICYP进行饱和实验,测量了CGP 20712A的高亲和力(β1肾上腺素能受体)和低亲和力(β2肾上腺素能受体)结合位点的密度。在心室膜中,CGP 20712A的高亲和力和低亲和力结合位点的比例分别为73%和27%,而在肌细胞膜中,相应的数字分别为90%和10%。在心室膜中,定义为在300 nM CGP 20712A存在下的[125I] - ICYP特异性结合的CGP 20712A低亲和力结合位点的密度,通过添加50 nM ICI 118,551而降低,而在肌细胞膜中则不受影响。4. 在肌细胞中,在存在300 nM CGP 20712A的情况下进行的饱和实验未检测到[125I] - ICYP和[3H] - CGP 12177的特异性结合。5. 在肌细胞中,在存在10 nM、100 nM或1000 nM CGP 20712A(选择性拮抗β1肾上腺素能受体)的情况下,未检测到由β2肾上腺素能受体引起的腺苷酸环化酶激活。此外,异丙肾上腺素刺激的环磷酸腺苷积累的浓度 - 反应曲线未因10 nM或100 nM ICI 118,551(选择性拮抗β2肾上腺素能受体)而移动,但因1000 nM ICI 118,551而向右移动。6. 这些结果表明,β2肾上腺素能受体不存在于大鼠心室肌细胞上,并且β2肾上腺素能受体刺激不会导致任何可检测到的环磷酸腺苷产生。我们得出结论,大鼠心室肌细胞上仅存在β1肾上腺素能受体。

相似文献

本文引用的文献

2
Some quantitative uses of drug antagonists.药物拮抗剂的一些定量应用。
Br J Pharmacol Chemother. 1959 Mar;14(1):48-58. doi: 10.1111/j.1476-5381.1959.tb00928.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验